Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 256

1.

[Chemotherapy for urothelial cancer of the bladder--update 2012].

Niegisch G, Lorch A, Albers P.

Aktuelle Urol. 2012 Dec;43(6):412-9. doi: 10.1055/s-0032-1327699. Epub 2012 Nov 29. Review. German.

PMID:
23196781
2.
3.

Importance of node dissection in relation to neoadjuvant and adjuvant therapy.

Huang WC, Bochner BH.

J Natl Compr Canc Netw. 2006 Nov;4(10):1019-26. Review.

PMID:
17112450
4.

[Is down-staging of advanced bladder cancer by neoadjuvant chemotherapy possible?--MVEC protocol].

Hoch V, Noll F, Schreiter F.

Urologe A. 1992 Jul;31(4):243-6. German.

PMID:
1514212
5.

Neoadjuvant chemotherapy preceding cystectomy for bladder cancer.

Sonpavde G, Amiel GE, Mims MP, Hayes TG, Lerner SP.

Expert Opin Pharmacother. 2008 Aug;9(11):1885-93. doi: 10.1517/14656566.9.11.1885 . Review.

PMID:
18627327
6.

[Systemic therapy of muscle invasive bladder cancer - an update].

Niedersüss-Beke D.

Wien Med Wochenschr. 2011 Aug;161(15-16):371-3. doi: 10.1007/s10354-011-0017-4. Review. German.

PMID:
21953426
7.

Neoadjuvant chemotherapy with cisplatin and methotrexate in patients with muscle-invasive bladder tumours.

Sengeløv L, von der Maase H, Lundbeck F, Barlebo H, Colstrup H, Engelholm SA, Krarup T, Madsen EL, Meyhoff HH, Mommsen S, Nielsen OS, Pedersen D, Steven K, Sørensen B.

Acta Oncol. 2002;41(5):447-56.

PMID:
12442921
8.

Radiation, chemotherapy and transurethral surgery: an organ-sparing alternative to the radical cystectomy.

Zietman AL.

Front Radiat Ther Oncol. 2002;36:131-46. Review. No abstract available.

PMID:
11842743
9.

Neoadjuvant chemotherapy for bladder cancer.

Sonpavde G, Lerner SP.

Oncology (Williston Park). 2007 Dec;21(14):1673-81; discussion 1686-8, 1691, 1694. Review.

10.

[Neoadjuvant chemotherapy: meta-analysis and interpretation of results in bladder cancer].

Pollera CF.

Suppl Tumori. 2004 Jul-Aug;3(4):S59-61. Review. Italian. No abstract available.

PMID:
15206215
11.

Chemotherapy and cystectomy for invasive transitional cell carcinoma of bladder.

Raghavan D.

Urol Oncol. 2003 Nov-Dec;21(6):468-74. Review.

PMID:
14693275
12.

[Adjuvant polychemotherapy after radical cystectomy of metastatic bladder cancer].

Stöckle M.

Urologe A. 1994 Nov;33(6):568-75. Review. German.

PMID:
7817458
13.

[Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].

Zapatero A, Pinar B, Arellano R, López M, Marín A, Jiménez U, Pérez Torrubia A.

Arch Esp Urol. 1997 Jun;50(5):448-54; discussion 454-6. Spanish.

PMID:
9382586
14.

Perioperative chemotherapy in advanced bladder cancer: part I. Neoadjuvant treatment.

Goebell PJ, Otto T, Rübben H.

Onkologie. 2003 Aug;26(4):361-5. Review.

PMID:
12972704
16.

[Locally advanced or metastatic bladder carcinoma. Current aspects of therapy].

Rübben H, Otto T.

Urologe A. 2001 Nov;40(6):464-7. German.

PMID:
11760352
17.

Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder.

Yeshchina O, Badalato GM, Wosnitzer MS, Hruby G, RoyChoudhury A, Benson MC, Petrylak DP, McKiernan JM.

Urology. 2012 Feb;79(2):384-90. doi: 10.1016/j.urology.2011.10.050. Epub 2011 Dec 22.

PMID:
22196406
18.

Expression of nucleoside transporters and deoxycytidine kinase proteins in muscle invasive urothelial carcinoma of the bladder: correlation with pathological response to neoadjuvant platinum/gemcitabine combination chemotherapy.

North S, El-Gehani F, Santos C, Ghosh S, Lai R, Cass CE, Mackey JR.

J Urol. 2014 Jan;191(1):35-9. doi: 10.1016/j.juro.2013.07.006. Epub 2013 Jul 10.

PMID:
23851183
19.

Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.

Segal R, Winquist E, Lukka H, Chin JL, Brundage M, Markman BR; Cancer Care Ontario Practice Guidelines Initiative Genitourinary Cancer Disease Site Group.

Can J Urol. 2002 Oct;9(5):1625-33.

PMID:
12431323
20.

Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series.

Weight CJ, Garcia JA, Hansel DE, Fergany AF, Campbell SC, Gong MC, Jones JS, Klein EA, Dreicer R, Stephenson AJ.

Cancer. 2009 Feb 15;115(4):792-9. doi: 10.1002/cncr.24106.

Supplemental Content

Support Center